Genetics and Inheritance of MDS
At a Glance
Myoclonus-dystonia syndrome is often linked to an SGCE mutation. Because the maternal copy is usually silenced, inheriting the mutation from a father is much more likely to cause symptoms than inheriting it from a mother, making genetic counseling important.
Genetic testing has transformed our understanding of Myoclonus-Dystonia Syndrome (MDS), moving it from a “mysterious” set of symptoms to a condition with an underlying biological cause. In about 30% to 50% of people with classic MDS, a mutation is found in the SGCE gene [1]. Understanding how this gene is passed down is essential, as it follows a unique and sometimes confusing rule called maternal imprinting.
The SGCE Gene: The Primary Blueprint
The SGCE gene provides instructions for making a protein called epsilon-sarcoglycan [2]. While scientists are still researching exactly what this protein does, it is found throughout the brain and is believed to help stabilize the connections between nerve cells (synapses) and regulate how calcium moves within those cells [3][4].
When there is a “typo” or mutation in this gene, the protein doesn’t work correctly, leading to the characteristic jerks and postures of MDS. While SGCE is the most common cause, researchers have identified other rare genes that can cause similar symptoms, such as KCTD17 and KCNN2, though evidence for these causing classic MDS is still emerging [5][6].
Maternal Imprinting: The “Silencing” Rule
Most of our genes come in pairs—one from our mother and one from our father—and both copies are usually active. However, SGCE is different because it is subject to maternal imprinting [7]. This means the copy of the gene inherited from the mother is naturally, though not invariably, “turned off” or silenced in the brain [8].
This leads to a specific pattern of inheritance:
- Inherited from the Father: If a child inherits the mutated gene from their father, the “active” copy is broken, and they have a very high chance (cohort estimates suggest around 95%) of developing symptoms [9][10].
- Inherited from the Mother: If a child inherits the mutated gene from their mother, it is usually silenced. These children often carry the mutation but do not show symptoms, though occasionally symptoms can still appear [9][11].
- De Novo Mutations: Sometimes, the mutation is not inherited at all but happens for the first time in the child (de novo). In these cases, neither parent carries the gene, though residual uncertainty like parental mosaicism (a mix of healthy and mutated cells) is possible [11][12].
Why Families Look Different: Penetrance and Expressivity
Even within the same family, MDS can look very different from person to person. This is due to two medical concepts:
- Incomplete Penetrance: Not everyone with the mutation will show symptoms. This is most common when the gene is inherited from the mother, but occasionally even a paternal inheritance results in no visible symptoms [9].
- Variable Expressivity: Relatives with the exact same mutation may have vastly different experiences. One person might have severe, life-altering jerks, while their sibling might only have a mild “writer’s cramp” or struggle with anxiety [13][14].
The Importance of Genetic Testing and Counseling
Because the inheritance pattern is so complex, professional genetic counseling is highly recommended for any family dealing with MDS.
- Confirming the Diagnosis: Genetic testing can support the diagnosis and help doctors rule out other conditions, though a negative result does not rule out clinically diagnosed MDS, and a Variant of Uncertain Significance (VUS) should not be treated as a definitive cause [1].
- Family Planning: A counselor can explain the specific risks for future children. For example, any person carrying the variant has a 50% chance of passing the gene to his or her children, but the chance of those children expressing symptoms depends heavily on whether it was passed by a father or a mother [9].
- Testing Relatives: Identifying carriers in the family can be important for their own family planning. Keep in mind that anxiety or OCD in a relative alone does not prove that person carries the MDS variant [13][15].
Testing should often include both sequencing (reading the gene) and deletion/duplication analysis (checking for missing chunks of the gene) to ensure no mutations are missed [11][16].
Common questions in this guide
What gene most often causes myoclonus-dystonia syndrome?
How does maternal imprinting affect MDS inheritance?
Can I have MDS even if my genetic test is negative?
What is the chance of passing an SGCE variant to my children?
What does a de novo mutation mean in MDS?
Can someone carry an SGCE variant without having visible jerks?
Get notified when new evidence is published on Myoclonus-dystonia syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Delineating the motor phenotype of SGCE-myoclonus dystonia syndrome.
Vanegas MI, Marcé-Grau A, Martí-Sánchez L, et al.
Parkinsonism & related disorders 2020; (80()):165-174 doi:10.1016/j.parkreldis.2020.09.023.
PMID: 33022436 - 2
Twenty years on: Myoclonus-dystonia and ε-sarcoglycan - neurodevelopment, channel, and signaling dysfunction.
Menozzi E, Balint B, Latorre A, et al.
Movement disorders : official journal of the Movement Disorder Society 2019; (34(11)):1588-1601 doi:10.1002/mds.27822.
PMID: 31449710 - 3
ε-Sarcoglycan: Unraveling the Myoclonus-Dystonia Gene.
Cazurro-Gutiérrez A, Marcé-Grau A, Correa-Vela M, et al.
Molecular neurobiology 2021; (58(8)):3938-3952 doi:10.1007/s12035-021-02391-0.
PMID: 33886091 - 4
Mutation in ε-Sarcoglycan Induces a Myoclonus-Dystonia Syndrome-Like Movement Disorder in Mice.
Li J, Liu Y, Li Q, et al.
Neuroscience bulletin 2021; (37(3)):311-322 doi:10.1007/s12264-020-00612-5.
PMID: 33355901 - 5
Beyond SGCE: expanding the clinical and molecular spectrum of KCTD17- and KCNN2-related myoclonus-dystonia.
Krygier M, Sitek EJ, Chylińska M, et al.
Frontiers in neurology 2026; (17()):1728361 doi:10.3389/fneur.2026.1728361.
PMID: 41982418 - 6
KCNN2 mutation in autosomal-dominant tremulous myoclonus-dystonia.
Balint B, Guerreiro R, Carmona S, et al.
European journal of neurology 2020; (27(8)):1471-1477 doi:10.1111/ene.14228.
PMID: 32212350 - 7
Faithful SGCE imprinting in iPSC-derived cortical neurons: an endogenous cellular model of myoclonus-dystonia.
Grütz K, Seibler P, Weissbach A, et al.
Scientific reports 2017; (7()):41156 doi:10.1038/srep41156.
PMID: 28155872 - 8
A Japanese family with dystonia due to a pathogenic variant in SGCE.
Morikawa T, Miura S, Fan L, et al.
Human genome variation 2022; (9(1)):29 doi:10.1038/s41439-022-00207-8.
PMID: 35995778 - 9
A Genetics Pearl for Counseling Patients with Epsilon-Sarcoglycan Myoclonus-Dystonia.
Higinbotham AS, DeBrosse SD, Kilbane CW
Tremor and other hyperkinetic movements (New York, N.Y.) 2023; (13()):24 doi:10.5334/tohm.783.
PMID: 37637852 - 10
From SGCE gene to symptoms: decoding myoclonus-dystonia.
Peng X, Lei X, Yang L, He D
Acta neurologica Belgica 2025; doi:10.1007/s13760-025-02935-4.
PMID: 41331696 - 11
[Clinical and genetic analysis of childhood-onset myoclonus dystonia syndrome caused by SGCE variants].
Tian XJ, Ding CH, Zhang YH, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2020; (58(2)):123-128 doi:10.3760/cma.j.issn.0578-1310.2020.02.011.
PMID: 32102149 - 12
Novel SGCE Mutation in a Patient With Myoclonus-Dystonia: A Case Report.
Klinman E, Gooch C, Perlmutter JS, et al.
Neurology. Genetics 2024; (10(2)):e200128 doi:10.1212/NXG.0000000000200128.
PMID: 38486676 - 13
Clinical phenotype heterogeneity in a family with ε-sarcoglycan gene mutation.
Kaczyńska J, Jamrozik Z, Szubiga M, et al.
Neurologia i neurochirurgia polska 2020; (54(1)):33-38 doi:10.5603/PJNNS.a2020.0005.
PMID: 31956970 - 14
A Novel SGCE Nonsense Variant Associated With Marked Intrafamilial Variability in a Turkish Family With Myoclonus-Dystonia.
Gultekin M, Prakash N, Ganos C, et al.
Movement disorders clinical practice 2019; (6(6)):479-482 doi:10.1002/mdc3.12805.
PMID: 31392249 - 15
Population Prevalence of Deleterious SGCE Variants.
LeDoux MS
Tremor and other hyperkinetic movements (New York, N.Y.) 2020; (10()):50 doi:10.5334/tohm.567.
PMID: 33200041 - 16
Progression of neuropsychiatric and cognitive features due to exons 2 to 5 deletion in the epsilon-sarcoglycan gene: a case report.
Multani N, Moro E, Lang A, et al.
Neurocase 2016; (22(2)):215-9 doi:10.1080/13554794.2015.1120312.
PMID: 26652670
This page explains SGCE inheritance and genetic testing in MDS for informational purposes only and does not constitute medical advice. A neurologist or genetic counselor can interpret your results and discuss personal risks and family planning.